PATENT CLAIM ANALYSIS

Application Number: 15862310
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["702", "019000"]

Abstract:
A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. Each blood glucose measurement is separated by a time interval and includes a blood glucose time associated with a time of measuring the blood glucose measurement. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment for tube-fed patients from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The subcutaneous insulin treatment program for tube-fed patients determines recommended insulin doses based on the blood glucose times. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.

Claim (Index 13):
A system comprising:\n a dosing controller including a data processing device and a non-transitory computer-readable medium in communication with the data processing device, the data processing device configured to perform operations comprising:\n executing a subcutaneous treatment program configured to display on a screen in communication with the data processing device a graphical user interface, wherein the subcutaneous treatment program is configured to:\n display, in the graphical user interface, a patient information input window and a blood glucose information window; \n receive, in the patient information input window, patient information comprising:\n a target blood glucose value of the patient; and \n recommended boluses of insulin for administration to the patient at sequential time intervals throughout a day; \n \n receive, in the blood glucose information window, a blood glucose input for a blood glucose measurement of the patient; and \n obtain a blood glucose time associated with measuring the blood glucose measurement; \n \n determining which of the sequential time intervals includes the blood glucose time for the blood glucose measurement of the patient; \n determining a correction bolus based on the blood glucose time by calculating:\n CB x =(BG\u2212BG Target )/CF; \n \n wherein CB is the correction bolus, BG is the blood glucose measurement, BG Target  is the target blood glucose value of the patient, and CF is a correction factor; and \n administering the recommended boluses and the correction bolus to the patient by transmitting the recommended boluses and the correction bolus from the data processing device to a dose administering system having a patient display at the sequential time interval that includes the blood glucose time for the blood glucose measurement of the patient, the patient display configured to display a first number of units of insulin corresponding to the recommended boluses and a second number of units of insulin corresponding to the correction bolus and trigger administration of the first number of units of insulin and the second number of units of insulin to the patient.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 86.0
- Lexical Diversity: 2.38889
- Patent Class: 702.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14524756', '14524918', '14938997', '15342606', '14922763']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.3880915049598898
- 35 USC 102 Novelty (BERT): 0.646399085675095
- Combined Prediction Score: 0.4139222630314104
- Mean Citation Score: 659.7472399999998
- Max Citation Score: 718.5857
- Similarity Product: 592.8096796898723

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test